CoChat

Young age: an independent risk factor for disease-free survival in women with operable breast cancer

Open access
Han, Wonshik, Kim, Seok Won, Ae Park, In, Kang, Daehee, Kim, Sung-Won, Youn, Yeo-Kyu, Oh, Seung Keun, Choe, Kuk Jin, Noh, Dong-Young · 2004 · BMC Cancer

The DOI matches its Crossref record; 40 of the 42 references it cites were found in a registry or an index.

Abstract

BACKGROUND: The incidence of breast cancer in young women (age < 35) is low. The biology of the disease in this age group is poorly understood, and there are conflicting data regarding the prognosis for these women compared to older patients. METHODS: We retrospectively analyzed 2040 consecutive primary invasive breast cancer patients who underwent surgical procedures at our institution between 1990 and 1999. The younger age group was defined as patients aged <35 years at the time of diagnosis. The clinicopathological characteristics and treatment outcomes were compared between younger and older age groups. RESULTS: A total of 256 (12.5%) patients were aged <35. There was a significantly higher incidence of nuclear grade 3 and medullary histological-type tumors in younger patients compared to older patients. Axillary lymph node status, T stage, histological grade, c-erbB2 expression and estrogen receptor status did not differ significantly between the two age groups. Younger patients had a greater probability of recurrence and death at all time periods. Although there was no significant difference in disease-free survival between the two age groups in lymph node-negative patients, the younger group showed worse prognosis among lymph node-positive patients (p < 0.001). In multivariate analysis, young age remained a significant predictor of recurrence (p = 0.010). CONCLUSION: Young age (<35) is an independent risk factor for relapse in operable breast cancer patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1471-2407-4-82

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 (A) Disease-free survival curves for women <35 vs. ≥ 35 years old. Patients younger than 35 had significantly worse outcomes than their older counterparts (p < 0.001). (B) Overall survival curves showing patients younger than 35 had significantly worse outcomes than their older counterparts (p = 0.002).
Figure 1 (A) Disease-free survival curves for women <35 vs. ≥ 35 years old. Patients younger than 35 had significantly worse outcomes than their older counterparts (p < 0.001). (B) Overall survival curves showing patients younger than 35 had significantly worse outcomes than their older counterparts (p = 0.002).CC BY · PubMed Central
Figure 2 (A) Disease-free survival curves in axillary lymph node-negative patients showing no significant difference between the two age groups (p = 0.223). (B) Disease-free survival curves in axillary lymph node-positive patients showing patients younger than 35 had significantly worse outcomes than their older counterparts (p < 0.001).
Figure 2 (A) Disease-free survival curves in axillary lymph node-negative patients showing no significant difference between the two age groups (p = 0.223). (B) Disease-free survival curves in axillary lymph node-positive patients showing patients younger than 35 had significantly worse outcomes than their older counterparts (p < 0.001).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 2

  1. Yoo KY Park SK Sung JH Kang D Kim YC Kang HS Suh JS Kim JS Yun IJ Han S Noh DY Choe KJ High risk groups for female breast cancer in Korea J Korean Cancer Ass 1998 30 435 439
  2. Korea Central Cancer Registry, Ministry of Health and Welfare, Republic of Korea 2002 Annual Report of the Korea Central Cancer Registry Seoul 2003

Cited by

  • Breast cancer in young women: an overview

    Anastasiadi, Z., Lianos, G. D., Ignatiadou, E., Harissis, H. V., & Mitsis, M. (2017) · Updates in Surgery · doi:10.1007/s13304-017-0424-1 · Cited by 603

    “Recent evidence suggests that young age at diagnosis of breast cancer represent an independent prognostic factor of survival [18].”
    Background
  • Meta-hallmarks of aging and cancer

    López-Otín, C., Pietrocola, F., Roiz-Valle, D., Galluzzi, L., & Kroemer, G. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2022.11.001 · Cited by 529

  • Age, Breast Cancer Subtype Approximation, and Local Recurrence After Breast-Conserving Therapy

    Arvold, N. D., Taghian, A. G., Niemierko, A., Abi Raad, R. F., Sreedhara, M., Nguyen, P. L., Bellon, J. R., Wong, J. S., Smith, B. L., & Harris, J. R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.1105 · Cited by 452

    “Young patient age has been reported to be a poor prognostic factor among women with breast cancer (BC).(1-4) Studies have variously defined young age as age at diagnosis younger than 35, 40, 45, or even 50 years, with reports demonstrating higher rates of local recurrence (LR) and lower survival when young women are c…”
    Background
  • Effects of Age on the Detection and Management of Breast Cancer

    McGuire, A., Brown, J., Malone, C., McLaughlin, R., & Kerin, M. (2015) · Cancers · doi:10.3390/cancers7020815 · Cited by 374

    “Prognosis of patients varies with age, as younger women tend to have more aggressive tumours (such as triple negative) and a higher recurrence rate [136–141].”
    Background
  • Epidemiology and prognosis of breast cancer in young women.

    Assi, H., Khoury, K. E., Dbouk, H., Khalil, L. E., Mouhieddine, T. H., & Saghir, N. S. E. (2013) · PubMed · doi:10.3978/j.issn.2072-1439.2013.05.24 · Cited by 306

    “Although the diagnosis of breast cancer is much less common in women under the age of 40 years, it can have a greater impact than in older counterparts, as it tends to present at a later stage, be more aggressive and have a poorer prognosis (8,9).”
    Background

See all 259

Metadata

Authors
Han, W., Kim, S. W., Ae Park, I., Kang, D., Kim, S.-W., Youn, Y.-K., Oh, S. K., Choe, K. J., & Noh, D.-Y.
Affiliations
Seoul National University (KR)
Corresponding author
Noh, Dong-Young
Venue
BMC Cancer
Published
2004-11-17
Volume
4
Issue
1
Pages
82-82
ISSN
1471-2407 (ISSN-L)
OpenAlex
W1505543598
Cited by
259
References
42
Citations by year
2026: 4 · 2025: 6 · 2024: 11 · 2023: 12 · 2022: 14 · 2021: 16 · 2020: 16 · 2019: 18 · 2018: 13 · 2017: 16 · 2016: 15 · 2015: 17 · 2014: 18 · 2013: 18 · 2012: 11
FWCI
2.23
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Cancer (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Seoul National University
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Breast Lesions and Carcinomas
  • Health Sciences › Medicine › Oncology › Cancer Risks and Factors
Keywords
young age, operable breast cancer, disease-free survival, prognosis, breast cancer recurrence, lymph node status, medullary carcinoma, nuclear grade, estrogen receptor, c-erbB-2, young women
MeSH terms
Adult, Age Factors, Breast Neoplasms, Female, Humans, Neoplasm Recurrence, Local, Retrospective Studies, Multivariate Analysis, Chi-Square Distribution, Disease-Free Survival

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.